Synthesis of lipophilic sila derivatives of N-acetylcysteineamide, a cell permeating thiol

Applied Organometallic Chemistry

Volumn 24, Issue 3, 2010, Pages 189-192

  Zakai, Uzma I ^a   Bikzhanova, Galina ^a   Staveness, Daryl ^a   Gately, Stephen ^b   West, Robert ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Silamed Inc   (United States)

Author keywords

Antioxidant; Blood brain barrier; Lipophilic; N acetyl L cysteine; Sila drugs

Indexed keywords

ACETYL-CYSTEINE; BLOOD-BRAIN BARRIER; CELL PENETRATION; N-ACETYL L-CYSTEINE; POTENT ANTIOXIDANTS; REACTIVE OXYGEN SPECIES; SYNTHESIS AND CHARACTERIZATION;

AMIDES; BIOCHEMISTRY; BLOOD; CELL MEMBRANES; CYTOLOGY; OXYGEN;

SYNTHESIS (CHEMICAL);

EID: 77449117591     PISSN: 02682605     EISSN: 10990739     Source Type: Journal    
DOI: 10.1002/aoc.1572     Document Type: Conference Paper

References (41)

1. M. Arakawa, Y. Ito, N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 2007, 6(4), 308.
2. S. Dodd, O. Dean, D. L. Copolov, G. S. Malhi, M. Berk, N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Exp. Opin. Biol. Ther. 2008, 8(12), 1955.
3. T. Yoshida, Amino acids as an antidote. Glutathione, cysteine, N-acetylcysteine, and taurine. Jap. J. Toxicol. 1993, 6(4), 369.
4. C. M.Newman, J. B.Warren, G.W. Taylor, A. R. Boobis, D. S. Davies, Rapid tolerance to the hypotensive effects of glyceryl trinitrate in the rat: prevention by N-acetyl-L- but not N-acetyl-D-cysteine. Br. J. Pharmacol. 1990, 99(4), 825.
5. R. W. Orrell,R. J. M. Lane,M. Ross,Asystematic reviewof antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotrophic Lateral Sclerosis 2008, 9(4), 195.
6. R. J. Flanagan, T. J. Meredith, Use of N-acetylcysteine in clinical toxicology. Am. J.Med. 1991, 91(3C), 131S-9.
7. W. Droege, R. Kinscherf, S. Mihm, D. Galter, S. Roth, H. Gmuender, T. Fischbach, M. Bockstette, Thiols and the immune system: effect of N-acetylcysteine on T cell system in human subjects. Meth. Enzymol. 1995, 251(Biothiols, Part A), 255.
8. T. Kalebic, A. Kinter, G. Poli, M. E. Anderson, A. Meister, A. S. Fauci, Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc. Natl Acad. Sci. USA 1991, 88(3), 986.
9. M. Quintiliani, The biological actions of the glutathione/disulfide system: an overview. NATO ASI Ser., Ser. A 1990, 197(Sulfur-Cent. React. Intermed. Chem. Biol.), 435.
10. M. Zafarullah, W. Q. Li, J. Sylvester, M. Ahmad, Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 2003, 60(1), 6.
11. K. R. Atkuri, J. J. Mantovani, L. A. Herzenberg, N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr. Opin.Pharmacol. 2007, 7(4), 355.
12. R. Ruffmann, A. Wendel, Reduced glutathione (GSH) rescue by N-acetylcysteine. Klin.Wochenschr. 1991, 69(18), 857.
13. F. J. T. Staal, M. T. Anderson, L. A. Herzenberg, Redox regulation of activation of NF-kB transcription factor complex: effects of N-acetylcysteine. Meth. Enzymol. 1995, 252(Biothiols, Part B), 168.
14. A. M. Sadowska, B. Manuel-y-Keenoy,W. A. De Backer, Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: A review. Pulm. Pharmacol. Ther. 2007, 20(1), 9.
15. S. De Flora, G. A. Rossi, A. De Flora, Metabolic, desmutagenic and anticarcinogenic effects of N-acetylcysteine. Respiration 1986, 50(suppl. 1), 43.
16. S. De Flora, A. Izzotti, A. Albini, F. D'Agostini, M. Bagnasco, R. Balansky, Antigenotoxic and cancer preventive mechanisms of N-acetyl-L-cysteine. Cancer Chemoprevention 2004, 1, 37.
17. S. D. Flora, R. Balansky, C. Bennicelli, A. Camoirano, F. D'Agostini, A. Izzotti, C. F. Cesarone, Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. Drugs, Diet Dis. 1995, 1, 151.
18. S. De Flora, C. F. Cesarone, R. M. Balansky, A. Albini, F. D'Agostini, C. Bennicelli, M. Bagnasco, A. Camoirano, L. Scatolini, et al. Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background. J. Cell. Biochem. 1995, (suppl. 22), 33.
19. W. Wu, G. Goldstein, C. Adams, R. H. Matthews, N. Ercal, Separation and quantification of N-acetyl-L-cysteine and N-acetyl-cysteineamide by HPLC with fluorescence detection. Biomed. Chromatogr. 2006, 20(5), 415.
20. B. Ates, L. Abraham, N. Ercal, Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radical Res. 2008, 42(4), 372.
21. J. Amer,D. Atlas, E. Fibach,N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochim. Biophys. Acta, Gen. Subjects 2008, 1780(2), 249.
22. X. Zhang, A. Banerjee, W. A. Banks, N. Ercal, N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res. 2009, 1275, 87.
23. L. Grinberg, E. Fibach, J. Amer, D. Atlas, N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radical Biol.Med. 2005, 38(1), 136.
24. D. Offen, Y. Gilgun-Sherki, Y. Barhum, M. Benhar, L. Grinberg, R. Reich, E. Melamed, D. Atlas, A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 2004, 89(5), 1241.
25. S. Penugonda, S.Mare, G. Goldstein, W. A. Banks, N. Ercal, Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res. 2005, 1056(2), 132.
26. T. O. Price, F. Uras, W. A. Banks, N. Ercal, A novel antioxidant Nacetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp. Neurol. 2006, 201(1), 193.
27. Y. Gilgun-Sherki, Y. Barhum, D. Atlas, E. Melamed, D. Offen, Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant. J.Mol. Neurosci. 2005, 27(1), 125.
28. P. J. Barnes, Reactive oxygen species and airway inflammation. Free Radical Biol.Med. 1990, 9(3), 235.
29. K. S. Lee, S. R. Kim, H. S. Park, S. J. Park, K. H. Min, K. Y. Lee, Y. H. Choe, S. H. Hong, H. J. Han, Y. R. Lee, J. S. Kim, D. Atlas, Y. C. Lee, A novel thiol compound,N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kB and hypoxia-inducible factor-1alpha. Exp. Mol. Med. 2007, 39(6), 756.
30. C. J. Doelman, A. Bast, Oxygen radicals in lung pathology. Free Radical Biol.Med. 1990, 9(5), 381.
31. A. M. Cantin, Potential for antioxidant therapy for cystic fibrosis. Curr. Opin. Pulm. Med. 2004, 10(6), 531.
32. W. Xu, S. C. Erzurum, Airways inflammation and reactive oxygen/nitrogen species in pulmonary hypertension. Oxidative Stress 2007, 259.
33. G. A. Bikzhanova, I. S. Toulokhonova, S. Gately, R. West, Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity. Silicon Chem. 2007, 3(3/4), 209.
34. S. Gately, R. West, Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds. Drug Dev. Res. 2007, 68(4), 156.
35. G. A. Showell, J. S. Mills, Chemistry challenges in lead optimization: silicon isosteres in drug discovery. Drug Discov. Today 2003, 8(12), 551.
36. S. Gately,WO Patent, 2008, 2008147814 (A1).
37. G. Caron, G. Ermondi, R. A. Scherrer, Lipophilicity, polarity, and hydrophobicity. Compreh. Med. Chem. II 2006, 5, 425.
38. R. Mannhold, Lipophilicity: its calculation and application in ADMET predictions. Solvay Pharm. Conf. 2006, 6(Virtual ADMET Assessment in Target Selection and Maturation), 43.
39. N. S. Shaikh, S. S. Bhor, A. S. Gajare, V. H. Deshpande, R. D. Wakharkar, Mild and facile procedure for clay-catalyzed acetonide protection and deprotection of N(Boc)-amino alcohols and protection of 1,2-diols. Tetrahedron Lett. 2004, 45(28), 5395.
40. M. D. Threadgill, A. P. Gledhill, Synthesis of peptides containing S-(N-alkylcarbamoyl)cysteine residues, metabolites of Nalkylformamides in rodents and in humans. J. Org. Chem. 1989,54(12), 2940.
41. J. C. Sheehan, D.-D. H. Yang, A new synthesis of cysteinyl peptides. J. Am. Chem. Soc. 1958, 80, 1158.